The regulation of quinolinic acid in human immunodeficiency virus-infected monocytes.


Journal Article

Quinolinic acid (Quin) is thought to underlie cognitive and motor dysfunctions for a variety of neurological disorders. Specifically, in human immunodeficiency virus (HIV)-associated dementia, Quin levels correlate with the degree of neurological dysfunction observed in affected individuals. Since recent data from our laboratories suggest that both HIV-1 infection and activation of brain macrophages are required for the development of neurotoxicity we examined Quin production during virus infection and immune activation. HIV-1 infection of monocytes induced low levels of Quin while lipopolysaccharide (LPS) or interferon-gamma (IFN-gamma) activation of the virus-infected cells elicited 10-fold higher levels. The combined effects of LPS and IFN-gamma for Quin production in HIV-infected monocytes was identical to each factor added alone. Little or no Quin was detected in unstimulated uninfected monocytes. LPS or IFN-gamma activation of uninfected monocytes produced substantially higher levels of Quin than found in similarly stimulated HIV-1-infected monocytes. These results were at variance to the production of tumor necrosis factor-alpha (TNF-alpha). Here, a 2-to 5-fold increase in TNF-alpha levels were observed in culture fluids of LPS-activated HIV-infected cells when compared to similarly stimulated uninfected monocytes. The effect of LPS-induced Quin production by HIV-infected monocytes was not altered by primary human astrocytes. These data suggest that Quin levels seen in HIV dementia are a reflection of macrophage/ microglial activation seen during advanced clinical disease. These findings could help explain, in part, why few HIV-1-infected brain macrophages can give rise to significant neurological impairments.

Full Text

Duke Authors

Cited Authors

  • Nottet, HS; Flanagan, EM; Flanagan, CR; Gelbard, HA; Gendelman, HE; Reinhard, JF

Published Date

  • April 1996

Published In

Volume / Issue

  • 2 / 2

Start / End Page

  • 111 - 117

PubMed ID

  • 8799202

Pubmed Central ID

  • 8799202

International Standard Serial Number (ISSN)

  • 1355-0284

Digital Object Identifier (DOI)

  • 10.3109/13550289609146544


  • eng

Conference Location

  • United States